Under construction – not a live service
Sign in

2025-520529-19-00CompletedPhase 1

A phase 1 Clinical Trial to Evaluate Safety and Immunogenecity of HIV SOSIP v8.2 763 Vaccine in healthy individuals

Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 Jan 2025

Next steps

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
12 (actual)
First submitted
9 Jan 2025
Start date
20 May 2026
Lead sponsor
Consorcio Centro De Investigacion Biomedica En Red
Diseases
HIV
EU CT number
2025-520529-19-00
EudraCT number
2021-003868-27

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 12
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Hospital Clinic de BarcelonaBarcelonaSpainCompleted

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.